Survey on biomarkers in human vocalizations

Overview

• Recent years have seen an increase in technologies that use speech to assess the health of the speaker.
• This survey paper proposes a general taxonomy of these technologies and provides an overview of current progress and challenges.
• Vocal biomarkers are often secondary measures that approximate signals from other sensors or identify underlying mental, cognitive, or physiological states.
• Measurement of these biomarkers involves disturbances and uncertainties that can be considered noise sources.
• The biomarkers are qualified in terms of the various sources of noise involved in their determination.
• While some proposed biomarkers have high error levels, there are others where the errors are expected to be low, making them more likely candidates for adoption in healthcare applications.

Plain English Explanation

The paper discusses technologies that use speech to assess health. These technologies look for vocal biomarkers - characteristics of a person's voice that can provide clues about their mental, cognitive, or physical state. For example, changes in a person's voice may indicate the onset of certain medical conditions.

However, measuring these vocal biomarkers is challenging because they can be influenced by various "noise" factors, such as environmental conditions or individual differences. The paper proposes a way to categorize these technologies and the different types of noise that can affect the biomarkers.

While some vocal biomarkers have high levels of error or uncertainty, the paper suggests that there are others where the errors are relatively low. These low-error biomarkers are more likely to be useful in real-world healthcare applications, such as monitoring patient health or detecting the early signs of illness.

Technical Explanation

The paper presents a taxonomy for the various technologies that use speech to assess health, categorizing them based on the type of vocal biomarkers they measure and the sources of noise and uncertainty involved.

Vocal biomarkers are often secondary measures that approximate signals from other sensors or identify underlying mental, cognitive, or physiological states. Measuring these biomarkers involves dealing with various disturbances and uncertainties, which can be viewed as noise sources.

The paper qualifies the biomarkers in terms of the different types of noise, such as environmental, individual, or measurement-related noise. While some proposed biomarkers have high error levels, the authors suggest that there are others where the errors are expected to be lower, making them more suitable for healthcare applications.

Critical Analysis

The paper provides a comprehensive overview of the current state of technologies that use speech to assess health, but it also acknowledges the significant challenges involved in this field.

One key limitation is the high level of noise and uncertainty associated with many of the proposed vocal biomarkers. The paper suggests that further research is needed to identify the biomarkers with the lowest error levels, which would be the most promising for practical healthcare applications.

Additionally, the paper does not delve deeply into the specific techniques or algorithms used by these technologies, nor does it provide a detailed evaluation of their performance. More empirical evidence would be needed to fully assess the viability and reliability of these approaches.

Finally, the paper does not address the potential ethical and privacy concerns that may arise from the use of speech-based health assessment technologies, particularly in the context of electronic health records and data privacy.

Conclusion

This survey paper provides a comprehensive overview of the current state of technologies that use speech to assess health. It proposes a taxonomy of these technologies and highlights the key challenges, particularly the issue of noise and uncertainty in the measurement of vocal biomarkers.

While some proposed biomarkers have high error levels, the paper suggests that there are others with lower errors that may be more suitable for healthcare applications. However, further research and empirical evaluation are needed to fully understand the viability and reliability of these approaches, as well as the potential ethical and privacy implications.

Overall, this paper offers a valuable contribution to the field by providing a framework for understanding the state of the art and the key challenges that need to be addressed in the development of speech-based health assessment technologies.